A Phase I and Pharmacokinetic Study to Evaluate Histone Deacetylase Inhibitor, Entinostat in Chinese Postmenopausal Women Patients With Locally Recurrent or Metastatic Breast Cancer
Phase of Trial: Phase I
Latest Information Update: 02 Feb 2018
At a glance
- Drugs Entinostat (Primary) ; Exemestane (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- Sponsors Eddingpharm
- 30 Jan 2018 Planned End Date changed from 1 Dec 2019 to 1 Sep 2018.
- 30 Jan 2018 Planned primary completion date changed from 1 Jul 2017 to 1 Mar 2018.
- 20 Sep 2016 Status changed from not yet recruiting to recruiting.